The amnestic disorders therapeutics market was valued at USD 3.81 Billion in 2025 and is expected to grow at a CAGR of 4.20%, reaching USD 5.75 Billion by 2035. The market growth is driven by increasing prevalence of memory disorders and development of novel cognitive therapies.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
4.2%
Value in USD Billion
2026-2035
*this image is indicative*
Region-wise, North America is expected to be the leading market on the basis of revenue, followed by Europe. The two regions will continue being the leading markets within the industry, bolstered by the high disposable income and developed healthcare infrastructure. Furthermore, the Asia Pacific region is expected to be the fastest-growing market, owing to the significant opportunities in countries such as India and China. The region is further aided by the rising per capita incomes, expanding healthcare infrastructure, and increasing geriatric population.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Amnestic disorders therapeutics are the treatment options of amnestic disorders, which is a category of disorders involving previously developed memory loss, loss of the ability to construct new memories, or loss of the ability to learn new knowledge.
On the basis of disease type, the industry is divided into:
Based on drug type, the industry can be segmented into:
Cholinesterase inhibitors are further divided into donepezil, rivastigmine, and galantamine, among others. The industry can be segmented on the basis of route of administration into oral and injectable.
On the basis of distribution channel, the industry is divided into:
By end users, the industry is categorised into:
On the basis of region, the industry is divided into:
The amnestic disorders therapeutics industry is being driven by the rising incidences of amnesia across the globe. This is further expected to grow in the forecast period, thus, further aiding the market growth. The rapidly growing geriatric population is also expected to bolster the industry. The amnestic disorders therapeutics industry is further enhanced by the high diagnosis rate, favourable reimbursement scenario, high disposable incomes, availability of a large number of hospitals, and a well-developed healthcare infrastructure in developed regions, such as North America and Europe. In the coming years, the rising R&D investments are expected to aid the growth of the industry further.
The report gives a detailed analysis of the following key players in the global amnestic disorders therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is projected to grow at a CAGR of 4.20% between 2026 and 2035.
The major drivers of the industry, such as rising disposable incomes, developing healthcare infrastructure, growing geriatric population, and increasing incidences of amnesia, are expected to aid the market growth.
The key trends guiding the growth of the market include the growing R&D investments in developing treatment options for amnesia.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The leading disease types in the industry are anterograde, retrograde, transient global, and infantile amnesia, among others.
The major drug types in the industry are cholinesterase inhibitors and memantine.
The significant routes of administration in the market are oral and injectable.
The leading distribution channels in the industry are hospital pharmacies, retail pharmacies, and online, among others.
The major end-users in the market are hospitals, special clinics, and home care, among others.
The major players in the industry are Eisai Co., Ltd., AbbVie Inc, Novartis AG, and Johnson & Johnson Services, Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distributional Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share